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Background 
Septic shock is characterized by cardiovascular and vasomotor failure that is induced by an uncontrolled 
cascade of inflammatory mediators such as TNFα, IL-1β and IL-6. In dogs, systemic bacterial infections, 
haemorrhage, trauma, gastric dilatation/volvulus and pancreatitis are the major causes of septic shock. 
While endotoxin is a recognized effector molecule that can initiate an inflammatory cascade, it has been 
reported that preconditioning with endotoxin can downregulate inflammatory cytokine responses to 
subsequent endotoxin challenge. This study reports the effect of endotoxin preconditioning on anti-TNFα 
activity present in plasma from canine donors.  
Materials and methods 
Plasma from preconditioned (Caniplas®) and normal dogs (FFP) was provided blind to the study by a 
commercial supplier (Plasvacc Pty Ltd). In vitro anti-TNFα activity in canine donor plasma was 
determined by a L929 murine cell TNFα inhibition bioassay using recombinant murine TNFα. In vivo 
effects were tested by a rat subcutaneous skin pouch model. Rats were pretreated for 3 days with either 
Caniplas®, FFP, saline (2 ml/day, s.c.) or carprofen (5 mg/kg, s.c.) and inflammation was induced by 
injecting monosodium urate crystals into the pouch (5 mg/ml in 5 ml saline). Fluid was taken from 
pouches at specified intervals for cell count, TNFα and IL-6 analysis. Data analysis: normalized data 
were fitted to a four-parameter logistic curve. The fitted midpoints were compared statistically for 
datasets using an F-test and calculated fitted hill slopes.  
Results 
In the rat skin pouch model, both Caniplas® and FFP reduced TNFα levels and Caniplas® was a more 
potent antagonist. The heightened anti-TNFα activity of Caniplas® compared with FFP was confirmed in 
the in vitro cell bioassay (Figure 1). Neither Caniplas® nor FFP reduced inflammatory cell infiltration or 
the levels of IL-6.  
Figure 1. In vitro TNFα dose-response to canine sera.  
Conclusion 
While we need to confirm the mechanism, we report that preconditioning with endotoxin does illicit 
specific anti-TNFα activity and that this observation has been confirmed in both in vitro testing and in 
vivo animal models. It is plausible that preconditioning animals with endotoxin induces an increase in 
the concentration of soluble TNFα receptors I and II in donor plasma, and that this is the probable 
source of TNFα antagonism. This report suggests that preconditioned plasma may be a beneficial 
treatment where inflammation causes increased expression of TNFα.  
 
